In an interview with Technology Networks, Dr. Daniel Reker discusses how machine learning is improving data-scarce areas of drug discovery.
The new coding model is the first time the brand has found its own models can be instrumental in its own development.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results